Bioelectric Medicine Market To Reach USD 32,345.8 Million by 2030, Says P&S Intelligence
28 Feb 2023
NEW YORK, Feb. 28, 2023 /PRNewswire/ -- The value of the
bioelectric medicine market was USD 21,532.1 million in 2022, and it will power at a rate of 5.2% in the future, to touch USD 32,345.8 million by 2030, as claimed by P&S Intelligence in its latest report.
Implantable Cardioverter Defibrillators Are Most Used
Implantable cardioverter defibrillators are the most used of all the products, because of their extensive range of applications. Their electrical stimulation capability makes them necessary for the treatment of atrial fibrillation, ventricular tachycardia, and atrial flutter.
Furthermore, they are employed in conjunction with other treatments, including medications or surgery.
The increasing occurrence of cardiac arrests and neurological ailments in the elderly population is pushing the growth of this category.
This part of society has a mounting requirement for implantable devices, including cardioverter defibrillators, deep-brain stimulators, cardiac pacemakers, and spinal cord stimulators.
Get the sample pages of this report:
https://www.psmarketresearch.com/market-analysis/bioelectric-medicine-market/report-sample
Bioelectric Medicine Need Highest among Arrhythmia Patients
The arrhythmia category dominates the industry with around 60% of the revenue, and it will attain the highest CAGR in the future. This is because of the growing patient pool with the issue of arrhythmias, which widely uses implantable cardioverter defibrillators and cardiac pacemakers.
Moreover, several players are stressing over the increase of their business prospects, via collaborations, mergers, and partnerships, which will allow them to upgrade their research scope too.
Bioelectric Medicine Demand Is Highest in North America
North America had the largest revenue share, of above 40%, in the past, because of the high R&D investments, rising acceptance of technologically progressive devices, existence of major players, and large hospital count. Furthermore, the increasing healthcare spending is a key factor powering the regional industry.
Moreover, APAC will grow the fastest because of the increasing prevalence of numerous health ailments, including, Alzheimer's disease, epilepsy, spinal cord injuries, and cardiac arrhythmias; increasing government expenditure on the healthcare infrastructure, and wide accessibility of clinical labs and new diagnostic technologies.
Increasing Acceptance of Implantable Electroceutical Devices
The implantable electroceutical devices category had the largest share, of about 80%, in the past. This is mainly credited to the increasing prevalence of numerous cardiovascular and neurological illnesses and the increasing count of product approvals.
Browse detailed report on Bioelectric Medicine Market Size, Growth, Development and Demand Forecast to 2030
Hospitals To Grow Fastest as End Users
Hospitals will have the fastest growth, of around 7%, in the years to come. This will be because of the availability of cutting-edge devices for the detection and treatment of neurological and hearing ailments and skilled healthcare providers at these institutions.
Several chronic ailments, for example, Alzheimer's, arrhythmias, epilepsy, chronic pain, and retinitis pigmentosa, result in the hospitalization of the patient. In 2022, as per the Alzheimer's Association, about 6.5 million Americans aged over 65 years and about 73% of those aged 75 or more had Alzheimer's.
Bioelectric Medicine Market Segmentation Coverage in The Report
Bioelectric Medicine Market by End User
Hospitals
Clinics
Ambulatory Surgery Centers
Bioelectric Medicine Market by Application
Arrhythmia
Pain Management
Ischemia
Bioelectric Medicine Market by Device Type
Implantable
Non-Invasive
Bioelectric Medicine Market by Product
Implantable Cardioverter Defibrillators
Spinal Cord Stimulators
Cochlear Implants
Deep-Brain Stimulators
Transcutaneous Electrical Nerve Stimulators
Vagus Nerve Stimulators
Sacral Nerve Stimulators
Retinal Implants
Bioelectric Medicine Market Regional Analysis
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia-Pacific
Japan
China
India
South Korea
Australia
Latin America
Brazil
Mexico
Middle East and Africa
Saudi Arabia
South Africa
U.A.E.
Browse More Reports Published by P&S
Smart Home Healthcare Market Trends, Development and Demand Forecast Report 2030
Generic Drugs Market Analysis, Development and Demand Forecast Report 2030
Biologics CDMO Secondary Packaging Market Size, Growth, Development and Demand Forecast Report 2030
Blockchain Technology in Healthcare Market Trends, Development and Demand Forecast Report 2030
About
P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter
Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg
SOURCE P&S Intelligence
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.